TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 187 filers reported holding TG THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,301,619 | -68.8% | 155,696 | -7.3% | 0.00% | -66.7% |
| Q2 2023 | $4,173,021 | +62.4% | 167,996 | -1.7% | 0.01% | +50.0% |
| Q1 2023 | $2,569,689 | +25.4% | 170,857 | -1.3% | 0.00% | +33.3% |
| Q4 2022 | $2,048,589 | +102.8% | 173,169 | +1.5% | 0.00% | +50.0% |
| Q3 2022 | $1,010,000 | +37.8% | 170,669 | -1.1% | 0.00% | +100.0% |
| Q2 2022 | $733,000 | -51.6% | 172,568 | +8.3% | 0.00% | -50.0% |
| Q1 2022 | $1,516,000 | -54.0% | 159,400 | -8.0% | 0.00% | -50.0% |
| Q4 2021 | $3,294,000 | -41.0% | 173,344 | +3.4% | 0.00% | -42.9% |
| Q3 2021 | $5,580,000 | -18.6% | 167,682 | -5.1% | 0.01% | -22.2% |
| Q2 2021 | $6,852,000 | -22.5% | 176,653 | -3.7% | 0.01% | -25.0% |
| Q1 2021 | $8,845,000 | -2.6% | 183,502 | +5.1% | 0.01% | -7.7% |
| Q4 2020 | $9,080,000 | +101.9% | 174,548 | +3.9% | 0.01% | +85.7% |
| Q3 2020 | $4,498,000 | +58.3% | 168,071 | +15.2% | 0.01% | +40.0% |
| Q2 2020 | $2,842,000 | +121.9% | 145,903 | +12.1% | 0.01% | +66.7% |
| Q1 2020 | $1,281,000 | -12.3% | 130,155 | -1.1% | 0.00% | +50.0% |
| Q4 2019 | $1,461,000 | +103.5% | 131,623 | +3.0% | 0.00% | +100.0% |
| Q3 2019 | $718,000 | -31.4% | 127,801 | +5.6% | 0.00% | -50.0% |
| Q2 2019 | $1,047,000 | +35.4% | 121,050 | +25.9% | 0.00% | 0.0% |
| Q1 2019 | $773,000 | +91.8% | 96,165 | -2.2% | 0.00% | +100.0% |
| Q4 2018 | $403,000 | -25.1% | 98,372 | +2.4% | 0.00% | 0.0% |
| Q3 2018 | $538,000 | -54.8% | 96,087 | +6.1% | 0.00% | -50.0% |
| Q2 2018 | $1,191,000 | +7.3% | 90,540 | +15.8% | 0.00% | 0.0% |
| Q1 2018 | $1,110,000 | +67.2% | 78,200 | -3.4% | 0.00% | +100.0% |
| Q4 2017 | $664,000 | -27.8% | 80,941 | +4.2% | 0.00% | -50.0% |
| Q3 2017 | $920,000 | +6.5% | 77,650 | -9.6% | 0.00% | 0.0% |
| Q2 2017 | $864,000 | -12.1% | 85,935 | +1.9% | 0.00% | 0.0% |
| Q1 2017 | $983,000 | +178.5% | 84,335 | +11.2% | 0.00% | +100.0% |
| Q4 2016 | $353,000 | -41.4% | 75,835 | -2.4% | 0.00% | 0.0% |
| Q3 2016 | $602,000 | +28.6% | 77,735 | +0.6% | 0.00% | 0.0% |
| Q2 2016 | $468,000 | -31.6% | 77,235 | -3.8% | 0.00% | 0.0% |
| Q1 2016 | $684,000 | -12.4% | 80,247 | +22.5% | 0.00% | -50.0% |
| Q4 2015 | $781,000 | +20.3% | 65,485 | +1.8% | 0.00% | 0.0% |
| Q3 2015 | $649,000 | -39.4% | 64,353 | -0.3% | 0.00% | -33.3% |
| Q2 2015 | $1,071,000 | +30.6% | 64,553 | +21.8% | 0.00% | +50.0% |
| Q1 2015 | $820,000 | +1.4% | 52,991 | +3.7% | 0.00% | 0.0% |
| Q4 2014 | $809,000 | +75.1% | 51,091 | +18.0% | 0.00% | +100.0% |
| Q3 2014 | $462,000 | +14.9% | 43,306 | +1.0% | 0.00% | 0.0% |
| Q2 2014 | $402,000 | +77.9% | 42,860 | +30.8% | 0.00% | 0.0% |
| Q1 2014 | $226,000 | +107.3% | 32,760 | +17.6% | 0.00% | – |
| Q4 2013 | $109,000 | -23.2% | 27,860 | 0.0% | 0.00% | – |
| Q3 2013 | $142,000 | 0.0% | 27,860 | +25.2% | 0.00% | – |
| Q2 2013 | $142,000 | – | 22,260 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 839,128 | $27,926,000 | 5.24% |
| RA Capital Management | 4,098,332 | $136,392,000 | 1.89% |
| KLK CAPITAL MANAGEMENT LLC | 45,762 | $1,523,000 | 1.40% |
| Antara Capital LP | 520,800 | $17,332,000 | 1.33% |
| Spotlight Asset Group, Inc. | 75,000 | $2,496,000 | 1.24% |
| Nicholas Investment Partners, LP | 485,838 | $16,169,000 | 1.18% |
| MAVERICK CAPITAL LTD | 3,296,451 | $109,706,000 | 1.11% |
| SECTORAL ASSET MANAGEMENT INC | 394,949 | $13,144,000 | 1.09% |
| 683 Capital Management, LLC | 828,271 | $27,565,000 | 1.08% |
| ACT CAPITAL MANAGEMENT, LLC | 60,000 | $1,997,000 | 1.04% |